α-Acetyldigoxin

α-Acetyldigoxin can be used in heart failure related research and is orally available. The bioavailability of α-Acetyldigoxin is lower than that of β-Acetyldigoxin when administered orally and intravenously[1].

Product Specifications

CAS Number

[5511-98-8]

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

Biochemical Assay Reagents

Type

Reference compound

Related Pathways

Others

Field of Research

Cardiovascular Disease

Assay Protocol

https://www.medchemexpress.com/α-acetyldigoxin.html

Purity

93.59

Smiles

O[C@@]12[C@@]([C@@H](C(CO3)=CC3=O)CC1)([C@@H](C[C@@]4([H])[C@@]2([H])CC[C@@]5([H])[C@@]4(CC[C@@H](C5)O[C@H]6C[C@@H]([C@@H]([C@H](O6)C)O[C@H]7C[C@@H]([C@@H]([C@H](O7)C)O[C@H]8C[C@@H]([C@@H]([C@H](O8)C)O)OC(C)=O)O)O)C)O)C

Molecular Formula

C43H66O15

Molecular Weight

822.98

Precautions

H302, H315, H319, H335

References & Citations

[1]Rietbrock N, et al. Isomerisierung und biologische Verfügbarkeit von beta- und alpha-acetyldigoxin [Isomerisation and bioavailability of beta- and alpha-acetyldigoxin (author's transl) ]. Klin Wochenschr. 1977 Jul 1;55 (13) :641-6. German.